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     The bacterium Pseudomonas aeruginosa is a common cause of infections, and infection with antibiotic-
resistant strains can be dangerous. The aim of the present study is to investigate the presence of the exoS 
and exoU genes and the formation of biofilms in clinically isolated P.aeruginosa strains. A total of 126 
samples were isolated, and P.aeruginosa was identified using biochemical tests. Bacterial genomic DNA 
was extracted, and the presence of the exoS and exoU genes were detected by PCR. Biofilms were formed 
by culturing P.aeruginosaon glass slides in rich medium. The exoU (76%) exoS (68%) genes were detected 
in of strains isolated from burn (burns caused by heat) patients, respectively. Among the 113 strains 
isolated from patients with burn infections. An improved understanding of virulence genes and biofilm 
formation in P.aeruginosa may facilitate the future development of novel vaccines and drug treatments. 
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INTRODUCTION 
       Pseudomonas aeruginosa is a Gram-
negative, aerobic, non-fermentative, rod-shaped 
and motile bacterium that is ubiquitous and very 
versatile. P.aeruginosa secretes a variety of 
pigments, including pyocyanin (blue-green), 
fluorescein (yellow-green), fluorescent, 
pyoverdin, and pyorubin (red-brown). 
P.aeruginosa does not produce spore and non-
acid-fast. This bacterium uses a unipolar 
fellagelum for motility [1-3]. Many strains of 
P.aeruginosa were initially isolated based on 
their ability to produce pyocyanin, their typical 
colony structure when grown on agar media, and 
their distinctive grapelike odor, which is due to 
the production of aminoacetophenone [4-6]. 
Because these bacteria can grow on most 
surfaces, including medical devices such as 
catheters, they are an important cause of 
nosocomial infections [7]. P.aeruginosa tends to 
form biofilms, which are complex bacterial 
communities that adhere to a variety of surfaces, 
including metals, plastics, and medical implant 
materials, and tissues. Growth in biofilms 
promotes bacterial survival; once a biofilm is 
formed, it is extremely difficult to destroy [8, 9]. 
P.aeruginosa are an important cause of corneal 
ulcers worldwide, with P.aeruginosa infection 
resulting in severe corneal opacity, ocular pain 
and visual impairment. One of the main causes of 
encomia infections, including pneumonia, 
urinary tract infections, surgical wound 
infections and bloodstream in fictions. 
Understanding bacterial virulence and, more 
generally, the host-pathogen relationship at the 
cellular and molecular level is essential to 
identify new targets and develop new strategies 
to fight infection [11]. P.aeruginosa harbors at 
least one or more exoS, exoT, exoU and exoY 
genes that translated into protein products related 
to type III secretion systems (TTSS). ExoS and 
exoT are bio functional enzymes that 75% amino 
acid identity and encode Gtpase-activating 
protein (GAP) and ADP-ribosyl transferase 
(ADP-RT) activities. ExoY is Adenylate Cyclase 
[11-13]. In addition to its ability to grow in 
biofilms, P.aeruginosa possesses other important 
virulence factors. Exos transfer the ADP-ribose 
moiety from NAD
+ 
to many eukaryotic cellular 
proteins. P.aeruginosa exoS is an adenosine 
diphosphate ribosyl transferase that is distinct 
from Pseudomonas toxin A [14, 15]. ExoU has 
phospholipase/lysophospholipase activity and 
disrupts eukaryotic cell membranes after 
translocation into the cell by type III secretion 
systems [16, 17]. The aim of present study was to 
characterize the presence of the exoS and exoU 
genes in clinically isolated P.aeruginosa strains. 
An improved understanding of these virulence 
factors is important for the future development of 
vaccines, because P.aeruginosa is an opportunistic 
bacterium that is resistant to common antibiotics. 





MATERIALS AND METHODS 
     A total of 126 strains of P.aeruginosa bacteria 
were collected from burnt (Burns caused by heat) 
infections of the patients hospitalized respectively 
in Motahary Hospital (Burn center) in Tehran. 
The present study was performed with a 
convenience sample that included newborns 
recruited from 2011 through 2013. Bacteria were 
isolated 72 women and 54 men patients, the 
patients were aged between 40 and 62 years. 
Bacterial strains and growth condition 
     Cultured on certified agar for 24 hours. Gram 
negative bacillus was recognized by gram 
staining, then catalase and oxidase tests were 
done. If these tests were positive, bacteria were 
recognized by SIM for detecting motility, Indolic 
and H2S production. Others biochemical tests 
[including Triple Sugar Iron (TSI), Methyl Red-
Voges-Proskauer (MR-VP), Oxidase 
Fermentation (OF), Urease broth, Citrate tests, 
Lysine and Ornithine Decarboxylase and growth 
in 42
°
C] were done  for detecting P.aeruginosa. 
All strains were stored in LB and 20% glycerol at 
-20
°
C was added. Single colonies were grown in 
50 ml LB medium at 37
°
C for 24 hours with 
shaking. After incubation, 1.5 of the medium was 
transferred to a new test tube and centrifugation 
was carried out at 12000 rpm for 1min at 4
°
C. 
Supernatants were discarded. When precipitate of 
bacteria were low, this process was repeated 2 or 3 
times. The chromosomal genome bacterium was 
extracted through DNA purification kit (MBST 
DNA Extraction). Cells were stored at -20
°
C for 
further experiments within a week. 
PCR-based genotyping assays 
      The oligonucleotide primers used in this study 
are given in table1. To design these primers first 
nucleotide sequence of genes were blasted in 
NCBI site. Then, the primers were made by 
Roobin Teb Gostar Company showed in Table 1. 
The genome was electrophoresed on agarose gel 
1% in voltage 50 Volt for 2 hours. PCR reaction 
with final 25µl concentration was done. Each 
reaction included 2.5 µl buffer of PCR, 1µl Deoxy 
nucleotide three phosphate (dNTP), 1µl of each 
primers, 1µl extracted genome, 0.5µl of Taq DNA 
Polymerase enzyme and 18µl  twice distilled 
water were  prepared. The exoU gene was 
amplified from p. aeruginosa by use of primers:  
FW: 5'- GCTAAGGCTTGGCGGAATA-3' 
(up-stream and amplification siza: 204 bp) 
RV: 5’-AGATCACACCCAGCGGTAAC-3' 
(downstream and amplification siza: 204 bp), and 
the exoS gene was amplified from p. aeruginosa 
by use of primers: 
FW: 5’-ATGTCAGCGGGATATCGAAC-3' (up-
stream and amplification siza: 230 bp), and RV: 
5’-CAGGCGTACATCCTGTTCCT-3' 
(downstream and amplification siza: 230 bp), 
PCR ( for exoU) was performed by use of pfu 
proofreading polymerase (strata gene), according 
to the following protocol: 94
°
C for 10 min, then 
25 cycles at 94
°
C for 30″, 56
°
C for 45″ and 72
°
C 
for min 45″, then a final extension at 72
°
C for 10 
min. Also, PCR ( for exoS) was performed by use 
of pfu proofreading polymerase (strata gene), 
according to the following protocol: 94
°
C for 10 
min, then 25 cycles at 94
°
C for 30″, 58°C for 45″ 
and 72
°
C for min 45″, then a final extension at 
72
°
C for 10 min. To investigate the reaction 
product, 5µl of production was transferred on 1% 
agarose gel to Electrophores. They were stained 
with Ethidium Bromide and photographed. In the 
present study, biofilms were formed on glass 
slides. First the slides were sterilized at 121
°
C. 
From a fresh culture of bacteria (18-24 hours) that 
have resentment equivalent to 0.5 mac far land, 
about 200 µl was removed and added to 20 ml 
BHI broth in a tube. Then it was poured into a 
sterile plate with one glass slide and they were 
stored at 37 
°
C for 6, 24, 48, 72 and 120 hours. 
After a period of time set, slides were removed 
slowly with sterile forceps and slowly were 
shaken in distilled water until BHI broth was 
washed on surface slides. Slides were dried at 
room temperature for at least 30 min. Then, the 
slides were stained with Safranin or without 




     126 strains of P.aeruginosa were isolated from 
215 burn injury patients hospitalized. From all of 
strains in this study 82 (71%) P.aeruginosa after 
cultivation on certified agar medium were 
produced green-blue pigments. Bacteria colonies 
were dispersed. For detection of exoS and the 
exoU PCR reaction was done and the following 
results were obtained. PCR results of exoU gene 
(204 bp) expression is shown in Figure 1. Also, 
PCR results of exoS gene (230 bp) expression is 

















Figure 2. After Electrophores an observation studied exoS gene (230bp) on a 1% agarose gel. 
 
 
Also, all strains were isolated from burn 
infection patients formed biofilms. Five days of 
biofilm structure, with vertical growth and the 
formation of water channels. The image of the 
P.aeruginosa biofilm after 6, 24, 48, and 72 
hour after the painting were photographed 
[Figure  3]. Prevalence of exoU and exoSgenes 
in patients with burn infections caused by heat, 
shown in Figure 5.Four different modes (exoU+ 
& exoS+, exoU+ & exoS-, exoU- & exoS+, 
exoU- & exoS-) were examined. In 54% of 
patients in both exoU and exoS gene expression 
have been, In contrast, 10% of burn infections 
caused by bacteria, the expression of both exoU 
and exoS genes are not shown. 22% of 
infections have shown only exoU gene 
expression, In contrast, exoS genes have been 
shown to burn 14% of the infections. 
 






Figure 3. Biofilms formed by P.aeruginosa at different times, 
A: 6- hour biofilms by optical microscope.    B: 6- hour biofilms by phase microscopy.  
C: 24- hour biofilms by optical microscope.  D: 24- hour biofilms by phase microscopy.  
E: 48- hour biofilms by optical microscope.  F: 48- hour biofilms by phase microscopy. 
G: 72- hour biofilms by optical microscope.  H: 72- hour biofilms by phase microscopy 
 






Figure4.prevalence of genes exoS, exoU infections in patients with burns 
 
DISCUSSION 
     In Iran and most country of the developing, 
P.aeruginosa is the major risk factor underlying 
bacterium infection. We mentioned in the 
previous section P.aeruginosa was the most 
common nosocomial infection in the Motahary 
Hospital. In a study conducted by Guggenheim 
et al in 2009 [18], Mohammadzadeh et al in 
2013 [19], Yah et al in 2006 [20], and Agnihotri 
et al in 2004 [21], which was done on burn 
wound samples, all of them reported that 
P.aeruginosa as the most common bacteria 
isolated from burn infections and it was 
consistent with the present study. In this study 
frequency of exoU gene in P.aeruginosa 
isolated from burn patients in Motahary 
Hospital was 76% a head bands of this gene. In 
a study done by Mitove et al on 202 samples in 
2010 reported 30.2 % frequency of this gene 
[22]. The result of the present study was similar 
to their study of frequency of exoU gene. The 
frequency of exoU gene in P.aeruginosa from 
burnt patients was 76%. In a studied by 
Bradbury et al in 2010 was conducted in 
Australia on 184 clinical and environmental 
samples, 18% of the patients had exoU gene. 
The difference may be due to the differences of 
isolated strains [23].  
In addition, the frequency of exoS gene isolated 
from burn infection was 68%. In a studied by 
Mitov et al conducted in 2010, on 202 clinical 
samples, the frequency of the exoS gene was 
reported 62.4% [22]. The result of their study 
was similar to the present study. Since most of 
the samples of burnt patients had exoU gene. It 
indicates that, this gene has an important role in 
bacterial infection, but it is not essential because 
some of the samples had not this gene.  In 
another study done by Idrisetalin 2012, on 44 
clinical samples [24], Win Stanley et al in 2005 
of 63 clinical samples [25], they reported the 
frequency of exoS gene 54.54%, 38% 
respectively. The results of their study were 
different from our study, this difference may be 
due to the dissimilarity strains of bacterium or 
the disparity years. Our findings verify an 
association between secretion of exoU and high 
levels of cytotoxicity. These results indicate that 
exoU is a predominant cytotoxin of 
P.aeruginosa.  
Despite reports of exoS-associated cytotoxic 
activity, exoS-secreting isolates were no more 
cytotoxic than non-secreting isolates, under the 
conditions of our assays. Exos mediated 
cytotoxicity has been reported to require longer 
coincubation times than exoU-mediated 
cytotoxicity [26]. P.aeruginosa develops 
resistance to the fluroquinolones primarily from 
acquiring target site mutations or 
overexpression of multidrug efflux pumps from 
the resistance-nodulation-division (RND) 
family. Confirming our previously published 
findings, Poole et al showed that the 
fluoroquinolone-resistant subpopulation is 
predominated by exoU+ strains in a large 
sample of respiratory isolates, despite the higher 
prevalence of exoS+ strains overall. This may 
be related to our observation that exoU+ strains 





more readily acquire multiple target site 
mutations and at a lower Minimal Inhibitory 
Concentration (MIC) than exoS+ strains [27].  
In addition, all of the P.aeruginosa isolated 
from burn and urinary patients formed 
biofilms. The samples which were isolated 
from patients with urinary tract infections 
formed poor biofilms in comparison to burn 
patients. Since exoU gene involved in biofilm 
formation and even the frequency of this 
genes were low in urinary tract infections, 
consequently, the quantity of biofilm 
formation in these patients was not high.  
Hence, one reason for the increase of 
mortality among burn patient is the speed and 
the quality of biofilm formation in these 
patients. The study done by Choy et al in 
2008, reported that clinical samples of 
P.aeruginosa could form biofilms, and the 
samples having exoU gene formed better 
biofilms. The results of our study were similar 
to theirs.  
The study done by Zaborina et al on clinical 
samples in 2006, indicated that exoU gene 
involved in biofilm formation in isolated cases. 
The results of the present study were consistent 
with them [28, 29]. 
 
CONCLUSION  
     The results of this study showed, 
P.aeruginosa bacteria isolated from burn 
patients established better biofilms. That is 
perhaps one reason for the high mortality in 
burn patients. Indeed, it is suggested to find 
ways to prevent exoU gene activity to prevent 
biofilm formation, especially in burn patients 
with high mortality.  
It is likely for exoS gene to play an important 
role in the infections caused by P.aeruginosa. 
Due to the advantages of molecular methods in 
diagnosis of opportunistic pathogenic bacteria, 
it could be convenient and swift technique to 
prevent the progress of infections and mortality 
among these patients. 
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